You are here

Home › U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk › U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

Primary tabs

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

Thu, 2023-02-23 16:54 — mike kraft
CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted in favor of use of Bavarian Nordic's Jynneos vaccine for all adults at risk of mpox during an outbreak. Reuters Reuters

...

The recommendation of the committee is based on studies that showed vaccine effectiveness of 66%-83% for patients with full vaccination and 36%-86% for partial vaccination with no severe adverse affect.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
Mpox
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks